Seizures and reproductive function: Insights from female rats with epilepsy

Annals of Neurology

Volumn 64, Issue 6, 2008, Pages 687-697

  Scharfman, Helen E ^a,b   Kim, Michelle ^a   Hintz, Tana M ^a   MacLusky, Neil J ^c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE METHYL BROMIDE; DIAZEPAM; ESTRADIOL; PILOCARPINE; PROGESTERONE; PROLACTIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPTIC STATE; ESTRADIOL BLOOD LEVEL; ESTRUS CYCLE; EXPERIMENTAL RAT; FEMALE; NONHUMAN; OVARY CYCLE; OVARY CYST; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RAT; REPRODUCTION; TEMPORAL LOBE EPILEPSY; TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; GONADAL STEROID HORMONES; POLYCYSTIC OVARY SYNDROME; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SEIZURES;

EID: 58149235154     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21518     Document Type: Article

References (67)

1. Svalheim S, Tauboll E, Bjornenak T, et al. Do women with epilepsy have increased frequency of menstrual disturbances? Seizure 2003;12:529-533.
2. Herzog AG. Menstrual disorders in women with epilepsy. Neurology 2006;66(6 S3):S23-S28.
3. Nappi C, Meo R, Di Carlo C, et al. Reduced fertility and neuroendocrine dysfunction in women with epilepsy. Gynecol Endocrinol 1994;8:133-145.
4. Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for reduced fertility in marriage. Epilepsia 1996;37:833-840.
5. Morrell MJ, Montouris GD. Reproductive disturbances in patients with epilepsy. Cleve Clin J Med 2004;71(suppl 2):S19-24.
6. Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001;42:1584-1589.
7. Harden CL. Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease. Epilepsy Curr 2005;5:142-146.
8. Isojärvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008;17:111-119.
9. Olafsson E, Hauser WA, Gudmundsson G. Fertility in patients with epilepsy: a population-based study. Neurology 1998;51:71-73.
10. Polson DW. Polycystic ovary syndrome and epilepsy - a gynaecological perspective. Seizure 2003;12:397-402.
11. Zawadzk JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992:377-384.
12. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
13. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
14. Duncan S. Polycystic ovarian syndrome in women with epilepsy: a review. Epilepsia 2001;42:60-65.
15. Bilo L, Meo R. Epilepsy and polycystic ovary syndrome: where is the link? Neurol Sci 2006;27:221-230.
16. Genton P, Bauer J, Duncan S, et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001;42:295-304.
17. Herzog AG, Schachter SC. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 2001;42:311-315.
18. Isojärvi JI, Taubøll E, Tapanainen JS, et al. On the association between valproate and polycystic ovary syndrome: a response and an alternative view. Epilepsia 2001;42:305-310.
19. Taubøll E, Isojärvi JI, Harbo HF, et al. Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats. Seizure 1999;8:490-493.
20. Herzog AG. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure 2008;17:101-110.
21. Edwards HE, Burnham WM, Mendonca A, et al. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res 1999;838:136-150.
22. Singh KB. Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril 2005;84(suppl 2):1228-1234.
23. Mahajan DK. Polycystic ovarian disease: animal models. Endocrinol Metab Clin North Am 1988;17:705-732.
24. Amado D, Verreschi IT, Berzaghi MP, Cavalheiro EA. Effects of intrahippocampal injection of kainic acid on estrous cycle in rats. Braz J Med Biol Res 1987;20:829-832.
25. Amado D, Cavalheiro EA. Hormonal and gestational parameters in female rats submitted to the pilocarpine model of epilepsy. Epilepsy Res 1998;266-274.
26. Amado D, Cavalheiro EA, Bentivoglio M. Epilepsy and hormonal regulation: the patterns of GnRH and galanin immunoreactivity in the hypothalamus of epileptic female rats. Epilepsy Res 1993;14:149-159.
27. Whitten W. Modification of the oestrus cycle of the mouse by external stimuli associated with the male. J Endocrinol 1956;13:299-303.
28. Scharfman HE, Mercurio TC, Goodman JH, et al. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor. J Neurosci 2003;23:11641-11652.
29. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 1975;96:219-226.
30. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002;62:609-614.
31. Mora OA, Cabrera MM. Pheromonal male-induced diestrus and cyclicity in aging intact and young estrogenized female rats. Biol Reprod 1994;50:603-606.
32. LeFevre J, McClintock MK. Reproductive senescence in female rats: a longitudinal study of individual differences in estrous cycles and behavior. Biol Reprod 1988;38:780-789.
33. vom Saal FS, Finch CE, Nelson JF. Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press, 1994:1213-1314.
34. Scharfman HE, Hintz TM, Gomez J, et al. Changes in hippocampal function of ovariectomized rats in response to estradiol replacement that simulates the preovulatory estrogen surge. Eur J Neurosci 2007;26:2595-2612.
35. Scharfman HE, Goodman JH, Rigoulot M-A, et al. Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol 2005;196:73-86.
36. Bauer J. Epilepsy and prolactin in adults: a clinical review. Epilepsy Res 1996;24:1-7.
37. Lin YY, Yen SH, Pan JT, et al. Transient elevation in plasma prolactin level in rats with temporal lobe status epilepticus. Neurology 1999;53:885-887.
38. Swartz CM, Dunbar E. Postictal prolactin elevations in rats. Neuropsychobiology 1983;10:1-6.
39. Freeman ME.The ovarian cycle of the rat. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press, 1988:1893-1928.
40. Sharp P, La Regina MC. The laboratory rat. New York: CRC Press, 1998.
41. Murialdo G, Galimberti CA, Magri F, et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997;20:519-526.
42. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995;36:355-359.
43. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-294.
44. Cavalheiro EA. The pilocarpine model of epilepsy. Ital J Neurol Sci 1995;16:33-37.
45. Coulter DA, McIntyre DC, Löscher W. Animal models of epilepsy: what can they tell us? Brain Pathol 2002;12:240-256.
46. Turski L, Cavalehrio DA, Czuczwar SJ, et al. The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm 1987;39:545-555.
47. Clifford DB, Olney JW, Maniotis A, et al. The functional anatomy and pathology of lithium-pilocarpine and high dose pilocarpine seizures. Neuroscience 1987;23:953-968.
48. Nehlig A, Dube C, Koning E. Status epilepticus induced by lithium-pilocarpine in the immature rat does not change the long-term susceptibility to seizures. Epilepsy Res 2002;51:189-197.
49. Bertram EH, Zhang D, Williamson JM. Multiple roles of midline dorsal thalamic nuclei in induction and spread of limbic seizures. Epilepsia 2008;49:256-268.
50. Bilo L, Meo R, Valentino R, et al. Abnormal patterns of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-711.
51. Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-310.
52. Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006;12:351-361.
53. Matalliotakis I, Kourtis A, Koukoura O, Panidis D. Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet 2006;274:187-197.
54. Hamed SA, Fida NM, Hamed EA. States of serum leptin and insulin in children with epilepsy. Risk predictors of weight gain. Eur J Paediatr Neurol (in press).
55. Ben-Menachem E. Weight issues for people with epilepsy - a review. Epilepsia. 2007;48(suppl 9):42-45.
56. St-Pierre LS, Persinger MA. Extreme obesity in female rats following prepuberal induction of lithium-pilocarpine seizures and a single injection of acepromazine. Epilepsy Behav 2005;7:411-418.
57. Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc Lond B Biol Sci 2006;361:1251-1263.
58. Carl GF, Critchfield JW, Thompson JL, et al. Genetically epilepsy-prone rats are characterized by altered tissue trace element concentrations. Epilepsia 1990;31:247-252.
59. Klitgaard H, Matagne A, Vanneste-Goemaere J, Margineanu DG. Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res 2002;51:93-107.
60. Suzuki S BC, Wise PM. Mechanisms of neuroprotection by estrogen. Endocrine 2006;29:209-215.
61. Singh M. Progesterone-induced neuroprotection. Endocrine 2006;29:271-274.
62. Uzüm G, Akgün-Dar K, Bahçekapili N, et al. Nitric oxide involvement in seizures elicited by pentylentetrazol and sex dependence. Int J Neurosci 2005;115:1503-1514.
63. Thomas J, Yang YC. Allylglycine-induced seizures in male and female rats. Physiol Behav 1991;49:1181-1183.
64. Pericić D, Manev H, Bujas M. Gonadal hormones and picrotoxin-induced convulsions in male and female rats. Brain Res 1996;736:174-179.
65. Tan M, Tan U. Sex difference in susceptibility to epileptic seizures in rats: importance of estrous cycle. Int J Neurosci 2001;108:175-191.
66. Bujas M, Pericić D, Jazvinsćak MI. Influence of gender and gonadectomy on bicuculline-induced convulsions and on GABAA receptors. Brain Res Bull 1997;43:411-416.
67. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006;77:611-615.